Feline tarsal tumours histological spectrum, risk factors and prognostic insights.

Clinical Context

Peer-reviewed veterinary literature continues to shape everyday decision-making for feline patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated

A study published in Journal of feline medicine and surgery in 2026 evaluated feline tarsal tumours: histological spectrum, risk factors and prognostic insights..

Key Findings

ObjectivesTarsal tumours are rare, but previous reports suggest a predilection for round cell tumours (RCTs) and soft tissue sarcomas (STSs) in this region. This study aimed to determine the proportion of RCTs among feline tarsal neoplasms, refine classification through histological revision and immunohistochemistry (IHC), assess potential risk factors and evaluate clinical outcomes based on tumour histotypes.MethodsA retrospective analysis of feline tarsal neoplasms diagnosed between 2010 and 2024 was conducted. Signalment, history, treatment and outcomes were collected for RCTs and STSs. All RCTs underwent histological review and IHC (CD3,...

Why It Matters for Veterinary Professionals

For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for feline patients.

Practical Interpretation

The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.

Clinical Takeaway

Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.

Read the full article here.